
Collage photo of Chadi Nabhan and Amer Zeidan
Jul 21, 2025, 20:13
Chadi Nabhan: Discussing the Recent VERONA Trial in High-Risk MDS with Amer Zeidan
Chadi Nabhan, Chief Medical Officer and Head of Strategy at Ryght, shared a post on X:
“In this Healthcare Unfiltered Express HUExpress, Amer Zeidan of Smilow Cancer Hospital joins me to discuss the recent VERONA trial in high-risk MDS and the negative results publicized. What is next for HR-MDS?”
More posts featuring Chadi Nabhan on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 21, 2025, 17:21
Jul 21, 2025, 17:01
Jul 21, 2025, 17:00